Bio-Path Holdings Announces Successful Completion of Cohort 7 of Phase Ib Clinical Trial Evaluating Liposomal Grb-2 in Acute Myeloid Leukemia HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results